Dare Bioscience, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Dare Bioscience, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Dare Bioscience, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 8.55M shares, a 91.3% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.55M -89.7M -91.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 8.55M -78.1M -90.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 101M +14.4M +16.7% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 8.33M -76.5M -90.2% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 98.3M +13.5M +15.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 86.6M +1.81M +2.14% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 86.2M +2.23M +2.66% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 84.8M +881K +1.05% Dec 31, 2022 10-K 2024-03-28
Q3 2022 84.8M +8.22M +10.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 84.8M +27.4M +47.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 83.9M +36.6M +77.4% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 83.9M +42.3M +102% Dec 31, 2021 10-K 2023-03-30
Q3 2021 76.6M +43M +128% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 57.4M +28.9M +101% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 47.3M +22.6M +91.5% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 41.6M +21.9M +111% Dec 31, 2020 10-K 2022-03-31
Q3 2020 33.6M +16.9M +101% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 28.5M +11.8M +71% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 24.7M +13.3M +116% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 19.7M +8.26M +72.3% Dec 31, 2019 10-K 2021-03-30
Q3 2019 16.7M +5.26M +46.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 16.7M +5.26M +46.1% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 11.4M 0 0% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 11.4M +5.38M +88.9% Dec 31, 2018 10-K 2020-03-27
Q3 2018 11.4M +5.38M +88.9% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 11.4M +2.32M +25.5% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 11.4M -17.6M -60.6% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 6.05M +5.14M +565% Dec 31, 2017 10-K 2019-04-01
Q3 2017 6.05M -21.3M -77.9% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 9.1M -18.3M -66.7% Jun 30, 2017 8-K/A 2017-10-02
Q1 2017 29M +1.66M +6.06% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 910K -7.29M -88.9% Dec 31, 2016 10-K 2018-03-28
Q3 2016 27.4M +37.7K +0.14% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 27.4M +63.9K +0.23% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 27.4M +6.8M +33% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 8.2M -11.9M -59.3% Dec 31, 2015 8-K/A 2017-10-02
Q3 2015 27.3M +7.22M +35.9% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 27.3M +7.18M +35.7% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 20.6M +19.8M +2492% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 20.1M +19.3M +2462% Dec 31, 2014 10-K 2016-03-10
Q3 2014 20.1M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 20.1M Jun 30, 2014 10-Q 2014-08-12
Q1 2014 794K Mar 31, 2014 10-Q 2014-05-27
Q4 2013 786K Dec 31, 2013 10-K 2015-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.